Baetz, T., Chen, B. E., Couban, S., Tom Kouroukis, C., Buckstein, R., Kuruvilla, J., Howson-Jan, K., Szwajcer, D., Federico, M., Meyer, R. M., Djurfeldt, M. S., Hay, A. E., Shepherd, L., & Crump, M. (2017). Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*. Leukemia and Lymphoma, 58(1), 64-69. https://doi.org/10.1080/10428194.2016.1187274
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*. / Baetz, Tara; Chen, Bingshu E.
; Couban, Stephen 等.
在:
Leukemia and Lymphoma, 卷 58, 号码 1, 02.01.2017, 页码 64-69.
科研成果: 期刊稿件 › 文章 › 同行评审
Baetz, T, Chen, BE, Couban, S, Tom Kouroukis, C, Buckstein, R, Kuruvilla, J, Howson-Jan, K, Szwajcer, D, Federico, M, Meyer, RM, Djurfeldt, MS, Hay, AE, Shepherd, L & Crump, M 2017, 'Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*', Leukemia and Lymphoma, 卷 58, 号码 1, 页码 64-69. https://doi.org/10.1080/10428194.2016.1187274
Baetz T, Chen BE, Couban S, Tom Kouroukis C, Buckstein R, Kuruvilla J 等. Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*. Leukemia and Lymphoma. 2017 1月 2;58(1):64-69. doi: 10.1080/10428194.2016.1187274
Baetz, Tara ; Chen, Bingshu E. ; Couban, Stephen 等. / Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma : a cohort comparison from the NCIC Clinical Trials Group Study LY.12*. 在: Leukemia and Lymphoma. 2017 ; 卷 58, 号码 1. 页码 64-69.
@article{5a852d131997448a8bd27c6e631d0e2a,
title = "Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*",
keywords = "Autologous transplant, rituximab, salvage chemotherapy",
author = "Tara Baetz and Chen, {Bingshu E.} and Stephen Couban and {Tom Kouroukis}, C. and Rena Buckstein and John Kuruvilla and Kang Howson-Jan and David Szwajcer and Massimo Federico and Meyer, {Ralph M.} and Djurfeldt, {Marina S.} and Hay, {Annette E.} and Lois Shepherd and Michael Crump",
note = "Publisher Copyright: {\textcopyright} 2016 Informa UK Limited, trading as Taylor & Francis Group.",
year = "2017",
month = jan,
day = "2",
doi = "10.1080/10428194.2016.1187274",
language = "English",
volume = "58",
pages = "64--69",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1",
}
TY - JOUR
T1 - Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma
T2 - a cohort comparison from the NCIC Clinical Trials Group Study LY.12*
AU - Baetz, Tara
AU - Chen, Bingshu E.
AU - Couban, Stephen
AU - Tom Kouroukis, C.
AU - Buckstein, Rena
AU - Kuruvilla, John
AU - Howson-Jan, Kang
AU - Szwajcer, David
AU - Federico, Massimo
AU - Meyer, Ralph M.
AU - Djurfeldt, Marina S.
AU - Hay, Annette E.
AU - Shepherd, Lois
AU - Crump, Michael
N1 - Publisher Copyright:
© 2016 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2017/1/2
Y1 - 2017/1/2
KW - Autologous transplant
KW - rituximab
KW - salvage chemotherapy
UR - http://www.scopus.com/inward/record.url?scp=84976274824&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84976274824&partnerID=8YFLogxK
U2 - 10.1080/10428194.2016.1187274
DO - 10.1080/10428194.2016.1187274
M3 - Article
C2 - 27266754
AN - SCOPUS:84976274824
SN - 1042-8194
VL - 58
SP - 64
EP - 69
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 1
ER -
